Robbe Van den Begin
Papers
1
Total Citations
9
H-Index
1
About
Robbe Van den Begin is a leading figure in radiation oncology, whose work centers on the precision and safety of stereotactic ablative body radiation therapy (SBRT) for extracranial cancers. His most cited research, "Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy" (2015, 9 citations), addresses a critical challenge: the risk of normal tissue injury and tumor miss due to respiratory motion. Van den Begin pioneered a first-of-its-kind SBRT platform that dynamically tracks lung tumors in real time, enabling high-precision, ablative radiation delivery. This contribution significantly reduces collateral damage to healthy tissue, enhancing treatment efficacy and patient safety. His work has been instrumental in advancing adaptive radiotherapy techniques, particularly for moving targets in the thorax and abdomen. With a citation impact that underscores its clinical relevance, Van den Begin’s research is a cornerstone for oncologists and physicists seeking to minimize treatment risks. His achievements have positioned him as a key innovator in the field, bridging the gap between technological development and practical application in cancer care.
Research Focus
Key Achievements
Top Papers
- 1